Author
There's a link between menopause and cholesterol that many women don't realize. The drop in estrogen that drives perimenopause and menopause also changes how your body makes, handles, and clears cholesterol. It’s a connection that sometimes goes unaddressed at routine checkups. If you're also experiencing bothersome menopausal symptoms, hormone therapy may be an important part of your overall treatment plan and may provide favorable effects on cholesterol in addition to symptom relief.
What You'll Learn in this Article
Q: Does menopause actually affect cholesterol?
A: Yes, and in a significant way. The drop in estrogen during perimenopause and menopause changes how your liver handles cholesterol, so LDL (the type linked to heart disease) tends to rise and HDL quality declines. So, even if your lab results are in the normal range, it’s worth discussing the role menopause is playing in your heart health..
Q: When do these changes start: during perimenopause or after?
A: Both, but the steepest shift happens during perimenopause, in the one to two years around your final period, which is often earlier than women expect and earlier than the cholesterol conversation usually starts.
Q: Is this a big deal for heart health?
A: It can be. Heart disease risk rises after menopause, and the lipid changes that begin during perimenopause are part of why. The SWAN Heart and HDL Ancillary studies found that LDL increases during the menopause transition are linked to higher rates of artery plaque later in life.
Q: Can hormone replacement therapy (HRT) help?
A: A study of women taking oral estrogen has been shown to lower LDL by about 11% and raise HDL by 7 to 13%. HRT isn't prescribed just for cholesterol, but if you're taking it for hot flashes, poor sleep, or other symptoms, the lipid benefit is a meaningful secondary benefit.
Q: What else can improve my cholesterol numbers?
A: Diet and exercise both have solid evidence behind them. Soluble fiber and the Mediterranean diet pattern can make a real, measurable difference.Statins remain the strongest option if lifestyle changes and HRT aren't enough.
How Estrogen Affects Your Cholesterol
Estrogen, and estradiol (a type of estrogen) in particular, plays a direct role in how your liver handles LDL. It increases the number of LDL receptors in your liver cells, which allows the liver to pull more LDL out of your blood and process it. Higher estradiol levels during the reproductive years generally have favorable effects on lipid metabolism
Estrogen also supports the production of HDL particles that scavenge cholesterol from artery walls and carry it back to the liver to be cleared. When estrogen falls, this clearing process becomes less effective, and cholesterol that would have been removed starts to build up.
Research from the SWAN study confirms that higher estradiol levels at midlife are directly linked to lower levels of small, dense LDL particles, which are the subtype most strongly tied to heart disease risk. This helps explain why heart disease rates in women are lower than in men during the childbearing years, and why that gap closes after menopause.
What Happens During Perimenopause: The Steepest Shift in Cholesterol Levels
Perimenopause is the transition before your final period, and it can last four to eight years. During this time, ovulation becomes irregular, and estrogen and progesterone levels swing widely instead of following a steady pattern from month to month. Even before estrogen drops to its post-menopause level, these swings are enough to start disrupting how your body handles cholesterol. The SWAN Heart and HDL Ancillary studies found that LDL rose most sharply in the one to two years around the final menstrual period, not in the post-menopausal years that follow. By the time menopause is confirmed, the biggest lipid shift has often already happened.
This timing matters. If you're in your late 40s or early 50s and your cholesterol has crept up over the past few years, perimenopause may be a contributing factor, even if your periods are still arriving in most months. A recent lipid panel is worth asking for if you don't have one.
What Happens After Menopause
After menopause (defined as 12 consecutive months without menstruation), estrogen stays at a low, steady level. LDL tends to hold at its elevated level or continue rising slowly, and triglycerides increase. HDL presents a more complex picture.
Your total HDL number may not drop much, which can make a post-menopause cholesterol panel look acceptable at a glance. But the SWAN HDL study found that large, protective HDL particles declined during the menopause transition while smaller, less effective particles increased, and a normal HDL number doesn't always reflect how well those particles are actually working. This is one reason heart disease risk assessments in post-menopausal women need more context than a single cholesterol reading.
Heart disease is the leading cause of death in women, and risk rises after menopause. The Menopause Society's 2022 position statement addresses this directly, and it's part of why menopause specialists treat lipid management as a standard part of midlife care rather than something to look at only when numbers are alarming.
The Cholesterol Picture: A Snapshot by Stage of the Menopause Transition
|
Marker |
Perimenopause |
Post-Menopause |
|---|---|---|
|
LDL cholesterol |
Rises sharply, especially near final period |
Stays elevated; may keep rising |
|
Total HDL cholesterol |
Modest decline |
May appear stable |
|
HDL particle quality |
Declines (more small, less effective particles) |
Continued decline |
|
Triglycerides |
Begin to rise |
Stay elevated |
|
Heart disease risk |
Increasing |
Notably higher than pre-menopause |
How to Lower Cholesterol During Menopause
These are evidence-based options, not a general list of things to try. You don't have to do all of them, but knowing what each one actually does helps you have a more useful conversation with your provider.
Dietary Changes that Move the Numbers
A 2024 review of Mediterranean diet studies in menopausal women found real drops in total cholesterol, LDL, and triglycerides across multiple trials. The diet's fat profile and high fiber content specifically support how the liver clears cholesterol, and this evidence is specific to women in this stage of life, not just general heart health research.
Soluble fiber deserves particular attention. A 2023 review of 181 randomized clinical trials found that each extra 5 grams of soluble fiber per day led to a measurable drop in LDL, with 5 to 10 grams per day linked to reductions of 5 to 11 points. Good sources of soluble fiber include:
- oats
- beans
- lentils
- psyllium
Cutting saturated fat from processed meats, full-fat dairy, and fried foods and replacing it with healthier unsaturated fats supports LDL clearance, while cutting refined carbohydrates helps bring triglycerides down.
Exercise
The evidence-based target for lipid management is 150 minutes of moderate aerobic exercise per week, though that doesn't mean 150 minutes of intense effort. Walking, swimming, and cycling all qualify, and strength training adds benefit for blood sugar control and weight, both of which affect triglycerides and HDL function.
Exercise doesn't produce large short-term drops in LDL, but it's one of the most effective tools for improving HDL function and lowering triglycerides, and its benefits for heart health extend well beyond what shows up on a cholesterol panel.
Hormone Replacement Therapy
If you're already considering HRT for hot flashes, sleep problems, or other menopause symptoms, the effects on cholesterol are worth factoring into the conversation. A placebo-controlled trial published in Fertility and Sterility found that oral estrogen reduced LDL by about 11% and raised HDL by 11 to 12% in post-menopausal women, with transdermal estrogen showing smaller but still positive lipid effects.The primary indication for menopausal hormone therapy is treatment of bothersome menopausal symptoms—not cholesterol management or cardiovascular disease prevention. However, favorable lipid effects may be an additional benefit for certain patients. A 2025 study in Climacteric found that hormone therapy started before age 60 was not linked to higher heart disease risk in women who were also taking statins, which supports using both together when each is clinically appropriate.
Statins and Other Medications
If lifestyle changes aren't enough to bring LDL into an appropriate range, your clinician may recommend lipid-lowering medication based on your overall cardiovascular risk. Statins are the most commonly used first-line medication. They reduce the liver's production of cholesterol and increase LDL receptor activity, which helps clear LDL from the blood, and they're well tolerated by most people and can be used alongside other treatments.Depending on your lipid pattern, your provider may also discuss fibrates for high triglycerides or PCSK9 inhibitors for very high LDL that doesn't respond to statins. These aren't first-line options, but they exist and are worth knowing about.
Getting Care That Connects These Dots
Most routine checkups don't include a conversation about how menopause is changing your heart disease risk profile. Cholesterol gets checked, a number gets flagged or doesn't, and the hormonal context usually doesn't come up.
A menopause specialist looks at this differently, because lipid management is part of a full midlife health review that includes your hormone status, your symptoms, and your personal risk factors. If your cholesterol numbers have changed and no one has connected that to where you are in the menopause transition, it's worth getting a second opinion from someone who specializes in this stage of life.
Book a visit with an Inflexxion Health clinician to talk through your cholesterol, your symptoms, and whether HRT or other treatment options make sense for you.
The Most Common Questions We Hear About Cholesterol during the Menopause Transition
Q: Why did my cholesterol suddenly get worse when I hit my ate 40s?
A: Perimenopause may be an important contributing factor. As estrogen becomes erratic during this stage, your liver loses some of its ability to clear LDL from the blood, and levels rise. This can happen years before your periods stop, so if your doctor hasn't connected the change to perimenopause, it's worth bringing up at your next visit.
Q: My HDL looks fine on my lab results. Does that mean I'm protected?
A: Not necessarily. Total HDL is not a complete picture of heart protection, especially after menopause. The SWAN HDL study found that large, effective HDL particles decline during the menopause transition while smaller, less useful ones increase, so a normal total HDL number may not reflect how well those particles are actually working. Your full lab picture matters more
Q: Will hormone replacement therapy (HRT) definitely help my cholesterol?
A: Oral estrogen lowers LDL and raises HDL in most women, but HRT is prescribed based on your overall clinical picture, not as a cholesterol treatment on its own. Your provider should weigh HRT alongside your personal heart disease risk factors and review options with you.
Q: I don't have symptoms. Do I still need to worry about cholesterol during menopause?
A: Yes. Cholesterol changes in menopause are driven by hormonal shifts, not by how you feel, and many women with significantly elevated LDL have no symptoms at all. Heart disease risk rises even when nothing feels wrong, which is why monitoring your lipids during and after the menopause transition is a reasonable thing to keep up with.
Q: How long does it take for diet and exercise changes to affect cholesterol?
A: Adding soluble fiber and cutting saturated fat can produce measurable LDL changes within four to six weeks, while exercise can lower triglycerides fairly quickly. HDL improvements from consistent exercise tend to take longer, around three to six months. These changes are real and worth making, but if your LDL is significantly elevated, lifestyle changes alone may not be enough to reach a healthy range.
This article is for informational and educational purposes and does not constitute medical advice. Please consult a qualified healthcare provider for evaluation and treatment recommendations specific to your situation.
References
- El Khoudary SR, et al. Low-density lipoprotein subclasses over the menopause transition and risk of coronary calcification and carotid atherosclerosis: The SWAN Heart and HDL Ancillary studies. PMC. 2023. https://pmc.ncbi.nlm.nih.gov/articles/PMC10539013/
- Karvonen-Gutierrez C, et al. HDL Subclasses, Lipid Content, and Function Trajectories Across the Menopause Transition: SWAN-HDL Study. J Clin Endocrinol Metab. 2021. https://pmc.ncbi.nlm.nih.gov/articles/PMC8105263/
- SWAN Study. Sex Hormone Levels at Midlife Linked to Bad Cholesterol Carriers that Increase Heart Disease Risk in Women. https://www.swanstudy.org/sex-hormone-levels...
- The North American Menopause Society. The 2022 hormone therapy position statement of The Menopause Society. Menopause. 2022. https://journals.lww.com/menopausejournal/...
- Abdelhamid AS, et al. Soluble Fiber Supplementation and Serum Lipid Profile: A Systematic Review and Dose-Response Meta-Analysis of Randomized Controlled Trials. Advances in Nutrition. 2023. https://pubmed.ncbi.nlm.nih.gov/36796439/
- Antoniou M, et al. Systematic review of Mediterranean diet interventions in menopausal women. AIMS Public Health. 2024. https://pubmed.ncbi.nlm.nih.gov/38617417/
- Kristensen MH, et al. Oral, more than transdermal, estrogen therapy improves lipids and lipoprotein(a) in postmenopausal women: a randomized, placebo-controlled study. Fertil Steril. 2004. https://pubmed.ncbi.nlm.nih.gov/14627865/
- Stuenkel CA, et al. Association of hormone therapy with cardiovascular events in females using statins for prevention. Climacteric. 2025. https://www.tandfonline.com/doi/full/10.1080/13697137.2025.2524171
